Moderna’s experimental mRNA cancer treatment progresses, shares spike
Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine designed to be tailored to individual patients based on unique mutations within their tumors.
We haven't written up this one. Global News has the full story — the link below goes straight to it.